Status:
WITHDRAWN
Oxytocin Dosing at Planned Cesarean Section and Anemia
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Blood Loss Anemia
Uterine Atony With Hemorrhage
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Patient's with planned cesarean sections will be randomized to receive either standard 20 mU in 1L as a bolus following delivery of the placenta or 20 mu in 1L following delivery of the placenta plus ...
Detailed Description
The purpose of this study is to examine the impact of differential dose protocols commonly utilized in the post cesarean period to determine if laboratory definitions of anemia are different. Oxytocin...
Eligibility Criteria
Inclusion
- Planned cesarean sections for singletons at or greater than 37 weeks gestational age
- Primary or repeat cesarean section will be included
Exclusion
- Multiple fetal pregnancies
- Hematologic disorders
- Fetal anomalies
- Pre-eclampsia. These patients are at increased risk of fluid overload and so fluid status may be affected by receiving a second bag of fluid containing oxytocin in the postpartum period.
- Known contraindication to oxytocin
- Hypersensitivity to oxytocin
- Patients who have labored and then proceed with cesarean section for any reason. Patients who have labored have had either intrinsic or extrinsic exposure to oxytocin. These patients may have decreased sensitivity to oxytocin.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03361124
Start Date
March 1 2019
End Date
March 1 2020
Last Update
February 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.